Months after announcing an M&A deal with AstraZeneca, EsoBiotec has released the first small slice of data on the cell ...

Trinity Biotech projects it reached Adjusted EBITDA1 -positive operations during Q2 2025 and expects to be Adjusted EBITDA1 positive going forward, reflecting continued strong execution on its ...

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), currently trading at $0.55 per share with a market capitalization of approximately $10 million, has received World Health Organization approval for ...

DUBLIN, June 24, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

An Ireland-based healthcare company is stealing the show so far during Tuesday’s session after it was announced that the company received World Health Organization (WHO) approval for the offshored and ...

News provided by Trinity Biotech plc Jun 24, 2025, 8:00 AM ET Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability ...

DUBLIN, June 24, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...